Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

BioMicroLab VC384 Automated Sample Management Syst

Active
75N98026Q00942Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Institutes of Health, Office of the Director, Office of Acquisitions, is soliciting commercial off-the-shelf solutions for the BioMicroLab VC384 Automated Sample Management System under solicitation number 75N98026Q00942. This competitive solicitation, issued under FAR Subpart 12.6 and Streamlined Solicitation guidelines, is designed for full and open competition without a set-aside and does not exceed the simplified acquisition threshold. Proposals must be submitted by August 19, 2026, and will be evaluated based on best value, with award anticipated as a firm-fixed-price contract. The acquisition falls under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees, and is unrestricted to all qualified vendors. The solicitation incorporates all applicable Federal Acquisition Regulation clauses in effect through August 3, 2026, and no separate written solicitation will be issued. All responses must be directed to the primary point of contact, Johnstn, Jaddua C, at jaddua.johnston@nih.gov, with the place of performance and office address located in Bethesda, Maryland.

General Info

NIH seeks BioMicroLab VC384 system via firm-fixed-price contract, due August 19, 2026, for Bethesda, Maryland delivery.

Agency

Department Of Health And Human Services → National Institutes Of Health OlaoView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(1)

RFQ 75N98026Q00942 BioMicroLab VC384 Automated Sample Management System

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
View Agency Profile
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00942. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 3, 2026

(iv) The associated NAICS code is 334516 ¿ Analytical Laboratory Instrument Manufacturing and the small business size standard is 1000 employees.

This requirement is unrestricted.

Similar Contracts

Same NAICS industry code

NAICS: 334516
New
DIBBS
MEASURING TUBE, GAS ANA
Solicitation # SPE2DH-26-T-5802
The measuring tube for gas analyzer is designed specifically to measure carbon dioxide content in compressed gases with a precise range of 100 to 3000 parts per million for one liter of air. It is constructed as a glass tube with melted tips for safe handling and is supplied in packages of ten units under the unit of issue PG. The item is governed by the DLA Master List of Technical and Quality Requirements, with applicable technical and quality standards referenced by R or I numbers. It is classified as a Type I (Code M) medical item with a mandatory non-extendable shelf life of 24 months, requiring that no more than three months have elapsed from the date of manufacture to the date of government delivery. All packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and labels must clearly indicate the date of manufacture, expiration or retest date, contract number, and lot number, following the latest revision of MMS1C. Packaging must ensure protection against damage and comply with DLA packaging requirements, using commercial-grade sealed containers and appropriate shipping packaging suitable for safe delivery via common carrier at the lowest cost to the specified point of delivery. The item is identified by NSN 6630-12-189-3126 and is procured under contract number SPE2DH-26-T-5802, with a required delivery within five days of award and a solicitation response deadline of August 11, 2026. Coverage of defense information applies, and removal of government identification from non-accepted supplies is required. The contracting office is under the Department of Defense, Medical Supply Chain FSH, with primary point of contact Tina Vu at the provided email and phone.
MEDICAL SUPPLY CHAIIN FSH

POSTED

about 23 hours ago

DEADLINE

in 6 days
View Details
NAICS: 334516
New
DIBBS
DETECTOR, METAL FLAW
Solicitation # SPE4A5-26-T-326N
The contract pertains to the procurement of two Metal Flaw Detectors, part number 23036190, under NSN 6635-01-717-8633, issued by the Department of Defense through DLA. The delivery is required within 171 days from the contract award, with shipment FOB origin and final inspection conducted at the destination. The entire shipment must comply with stringent packaging standards outlined in ASTM D3951, though DLA Master List of Technical and Quality Requirements override any conflicting provisions. Packaging and labeling must adhere to MIL-STD-129, and palletization must follow DLA-specific packaging guidelines. The unit of issue is each, with no variance allowed in quantity, and the delivery address is the DDSP New Cumberland Facility in Pennsylvania. Sampling and quality verification must conform to MIL-STD-1916 or ASQ H1331 Table 1 with zero non-conformances required unless otherwise specified, and attributes not explicitly defined are treated as major with a verification level of IV or AQL of 1.0. The contract incorporates all relevant technical and quality requirements from the DLA Master List, which control over any other referenced standards. The supplier must ensure complete removal of government identification from non-accepted items. The point of contact for inquiries is Brandy Coward, and the solicitation response deadline was August 12, 2026, with a required ship date of January 31, 2027, and original delivery expected by June 19, 2027.
ASC SUPPLIER OPER OEM DIVISION

POSTED

about 23 hours ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
Oxygen Candle Test Equipment Design & ManufacturingThe contract involves the design and manufacture of a fully integrated turnkey oxygen candle test system that must meet the stringent requirements of MIL-DTL-32789. The system is to support comprehensive burn testing of oxygen candles along with precise measurement of combustion byproducts and real-time data acquisition capabilities. The equipment must be engineered for reliability and accuracy in a controlled environment to ensure valid performance data under military specifications. All aspects of development, from conceptual design through final fabrication and integration, are included within the scope of work. The system is to be delivered and performed at a physical location in Philadelphia with a ZIP code of 19111. The solicitation was posted on August 4, 2026, with a firm response deadline of August 18, 2026. This is classified as a subcontract under NAICS code 334516, indicating it falls within the category of instrumentation manufacturing for scientific and industrial applications. The contracting entity is the DCSO-COLUMBUS-DIVISION-2 under the Department of Defense, indicating the end-user is a U.S. military or defense-related organization requiring certified, mission-critical equipment. No set-aside status is specified, and the contract does not include a point of contact, suggesting inquiries may be handled through standard SAM.gov channels.
DCSO-COLUMBUS-DIVISION-2

POSTED

1 day ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 424690
New
Federal
Supply of Research Reagents and DietsThe contract entails the supply of specialized research reagents and diets essential for preclinical disease modeling, including adenine-enriched diets, high-sucrose and high-fat diets, streptozotocin, and associated ancillary reagents required to induce and maintain metabolic and renal disease models in animal studies. These materials are critical for supporting biomedical research aimed at understanding chronic conditions such as diabetes, kidney disease, and metabolic syndrome under controlled experimental conditions. The reagents must meet strict quality and consistency standards to ensure reproducibility and validity of research outcomes across multiple investigative sites. This subcontract, issued under the National Institutes of Health under the Department of Health and Human Services, is classified under NAICS code 424690 for medical and dental equipment and supplies merchant wholesalers. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026. Performance is expected to support research activities managed by federal entities, though specific locations for delivery or use are not detailed. Suppliers must be prepared to comply with federal procurement requirements, deliver reagents in appropriate formulations and quantities, and ensure traceability and documentation for all provided items to facilitate regulatory and scientific compliance.
Other Chemical and Allied Products Merchant Wholesalers

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541690
New
Federal
Efficacy Study – HSHFD+STZ-Induced Diabetic Kidney Disease ModelThe contract outlines a commissioned efficacy study to evaluate the impact of an NNMT inhibitor in a mouse model of diabetic kidney disease induced by a high-sodium, high-fat diet combined with streptozotocin. The study requires comprehensive metabolic monitoring throughout the treatment period, precise dosing regimens, and systematic collection of tissue samples for downstream analysis. Endpoint evaluation will include detailed assessment of renal function, histopathological changes, and molecular markers associated with disease progression and therapeutic response. All procedures must adhere to standardized protocols to ensure data reliability and reproducibility, with results intended to support further development of the inhibitor as a potential therapeutic agent. The work is being pursued under a subcontract agreement issued by the National Institutes of Health through the Department of Health and Human Services, classified under NAICS code 541690 for other scientific research and development services. The solicitation was posted on August 4, 2026, with a response deadline of August 19, 2026. The contract does not specify a place of performance or point of contact, and no set-aside provisions are indicated. The project is positioned as a critical preclinical step in advancing an NNMT-targeted intervention for diabetic kidney disease, with findings expected to inform future clinical translation and funding decisions.
Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 541714
New
Federal
Evaluation of a Lead NNMT Inhibitor in Humanized M
Solicitation # 75N98026Q00941
The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed price contract to GemPharmatech LLC for the evaluation of a lead NNMT inhibitor using a humanized nicotinamide N-methyltransferase mouse model, a model uniquely developed and maintained by GemPharmatech under prior NIH funding. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603 and 41 U.S.C. 1901, and justified under the sole source exception for unique capabilities, as GemPharmatech is the only entity with the cryopreserved sperm and breeding resources necessary to regenerate the required mouse colony essential for generating scientifically relevant efficacy data due to the inhibitor's species-specific activity. The solicitation number is 75N98026Q00941, issued as a combined synopsis and solicitation without competitive procedures, and responses are due by August 19, 2026. The work falls under NAICS code 541714 for Research and Development in Biotechnology with a small business size standard of 1,000 employees, and this requirement is not set aside for small business. The contract will be managed by the NIH Office of Acquisitions based in Bethesda, Maryland, with the primary point of contact being Johnstona C. Johnston, reachable via email. All provisions and clauses follow those in effect through the Federal Acquisition Circular dated August 4, 2026, and the notice serves as the complete and only solicitation document; no additional written solicitation will be issued. The performance location is not specified beyond the federal agency's administrative details.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 14 days
View Details
NAICS: 325413
New
Federal
Fisher Scientific Reagents and Consumable Materials for Cell Therapy Manufacturing
Solicitation # 26-008155
The National Institutes of Health Clinical Center plans to award a sole-source firm-fixed-price purchase order to Fisher Scientific for validated reagents and consumable materials essential to the manufacturing of FDA-regulated cell-based therapies used in NIH clinical trials. These materials have been rigorously validated and approved by the Center for Cellular Engineering’s Quality Assurance Department to ensure consistent quality, safety, and efficacy in producing cell therapies for patient care. Any substitution of these materials would necessitate extensive and costly revalidation of manufacturing processes, leading to significant delays and potential risks to ongoing clinical trials, making Fisher Scientific the only viable supplier capable of providing the required validated products and supporting documentation compliant with federal regulatory standards. The acquisition is authorized under FAR 13.106-1(b)(1)(i), which allows for single-source procurement when only one provider can meet the government’s specific requirements, and the value does not exceed the simplified acquisition threshold. The product service code is 6550, and the NAICS code is 325413, classifying the items as in-vitro diagnostic substances. Performance will occur at the NIH Clinical Center in Bethesda, Maryland. While this notice does not solicit bids or proposals, responsible parties may submit capability statements by August 13, 2026, at 6:00 p.m. Eastern Time, referencing POTS 26-008155, though the government retains full discretion to proceed without competition. All inquiries should be directed to Shasheshe Goolsby of the Hospital and Laboratory Support Division.
In-Vitro Diagnostic Substance Manufacturing

POSTED

1 day ago

DEADLINE

in 8 days
View Details